Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Device Firms Seek More Exemptions, Pricing Flexibility For Oncoming Excise Tax

This article was originally published in The Gray Sheet

Executive Summary

Written comments were due May 7 on the Internal Revenue Service’s proposed regulation to implement a 2.3% excise tax on device sales in the lead-up to a May 16 public hearing.


Related Content

Final IRS Device Tax Rule Changes Little From Draft As Industry Focuses On Repeal Effort
Washington Roundup, November-December 2012
Post-Election Picture: Near-Term Next Steps To Come
News In Brief
Public Hearing: IRS Tight-Lipped On Industry Device Tax Concerns
Device Tax Repeal As Tax Reform: AdvaMed Makes The Case
Tax Time Cometh: IRS Issues Device Tax Proposed Rule





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts